Cervical Dystonia Market to Witness Robust Growth During the Forecast Period (2026-2036) Driven by the Expanding Therapeutic Options | DelveInsight
The cervical dystonia market is expected to increase due to an increase in disease prevalence during the forecast period. Additionally, the expected launch of emerging therapies such as ABP-450 (prabotulinumtoxinA) (AEON Biopharma), IPN10200 (Ipsen), MTR-601 (Mitra Biosciences), VIM0423...
The cervical dystonia market is expected to increase due to an increase in disease prevalence during the forecast period. Additionally, the expected launch of emerging therapies such as ABP-450 (prabotulinumtoxinA) (AEON Biopharma), IPN10200 (Ipsen), MTR-601 (Mitra Biosciences), VIM0423...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.